SIEPX | VTISX | SIEPX / VTISX | |
Total Expense Ratio | 2.40 | 0.05 | 5,106% |
Annual Report Gross Expense Ratio | 2.40 | 0.05 | 5,106% |
Fund Existence | 31 years | 9 years | - |
Gain YTD | 23.295 | 18.319 | 127% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 3000000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 3.37M | 511B | 0% |
Annual Yield % from dividends | 0.58 | 2.85 | 20% |
Returns for 1 year | 23.15 | 15.03 | 154% |
Returns for 3 years | 48.32 | 34.09 | 142% |
Returns for 5 years | 62.94 | 38.03 | 166% |
Returns for 10 years | 44.55 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
MTUL | 34.91 | N/A | N/A |
ETRACS 2x Lvrgd MSCI US Mntm Fctr TR ETN | |||
DMO | 11.81 | -0.01 | -0.13% |
Western Asset Mortgage Opportunity Fund | |||
RSJN | 33.34 | -0.08 | -0.23% |
FT Vest U.S. Eq Eq Wght Buffr ETF - Jun | |||
DFLV | 31.84 | -0.17 | -0.53% |
Dimensional US Large Cap Value ETF | |||
PPH | 88.45 | -1.22 | -1.36% |
VanEck Pharmaceutical ETF |